Ken Macleod
InvestorPartner at Rosetta Capital Ltd.
About
Kenneth MacLeod joined Rosetta Capital as a Partner in 2021, bringing over 35 years of life sciences experience across operating roles at healthcare companies (Abbott Labs., Serono) and fund management (SV Health Investors, Paul Capital, Visium Healthcare Partners). He holds board seats at JenaValve Technologies and Oxular, and holds a BSc from the University of Manchester and a D.Phil from the University of York.
Invests in
BiotechHealthtechMedical Devices
Investments
Board seats
JenaValve Technologies, inc.On-X Life Technologies, Inc.Oxular LimitedPharming Group N.V.SpePharm Holding B.V.
Per the firm's website.
Colleagues at Rosetta Capital Ltd.
Donovan Leung
Investment Manager at Rosetta Capital Ltd.
Graham Fagg
Partner Emeritus at Rosetta Capital Ltd.
Jonathan Hepple
Managing Partner at Rosetta Capital Ltd.
Matthew James
Chief Financial Officer at Rosetta Capital Ltd.
Michael Forer
Partner at Rosetta Capital Ltd.
Namrata Turaga
Investment Manager at Rosetta Capital Ltd.